Anaphylaxis after SonoVue: A Case Report and a Literature Review
Abstract
:1. Introduction
2. Methods
3. Case Report
4. Discussion
5. Conclusions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Available online: https://www.ema.europa.eu/en/documents/product-information/sonovue-epar-product-information_it.pdf (accessed on 13 July 2024).
- Schneider, M.; Arditi, M.; Barrau, M.B.; Brochot, J.; Broillet, A.; Ventrone, R.; Yan, F. BR1: A new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Investig. Radiol. 1995, 30, 451–457. [Google Scholar] [CrossRef] [PubMed]
- Schneider, M. Characteristics of SonoVuetrade mark. Echocardiography 1999, 16 Pt 2, 743–746. [Google Scholar] [CrossRef] [PubMed]
- De Groot, M.C.; van Zwieten-Boot, B.J.; van Grootheest, A.C. Ernstige bijwerkingen bij gebruik van zwavelhexafluoride (SonoVue) als echografisch contrastmiddel [Severe adverse reactions after the use of sulphur hexafluoride (SonoVue) as an ultrasonographic contrast agent]. Ned. Tijdschr. Voor Geneeskd. 2004, 148, 1887–1888. (In Dutch) [Google Scholar]
- Dijkmans, P.A.; Visser, C.A.; Kamp, O. Adverse reactions to ultrasound contrast agents: Is the risk worth the benefit? Eur. J. Echocardiogr. 2005, 6, 363–366. [Google Scholar] [CrossRef] [PubMed]
- Brockow, K.; Garvey, L.H.; Aberer, W.; Atanaskovic-Markovic, M.; Barbaud, A.; Bilo, M.B.; Bircher, A.; Blanca, M.; Bonadonna, B.; Campi, P.; et al. Skin test concentrations for systemically administered drugs—An ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2013, 68, 702–712. [Google Scholar] [CrossRef] [PubMed]
- Coudray, S.; Fabre, C.; Aichoun, I.; Perez-Martin, A. Anaphylactic shock with an ultrasound contrast agent. J. Med. Vasc. 2017, 42, 384–387. [Google Scholar] [CrossRef] [PubMed]
- Geleijnse, M.L.; Nemes, A.; Vletter, W.B.; Michels, M.; Soliman, O.I.; Caliskan, K.; Galema, T.W.; ten Cate, F.J. Adverse reactions after the use of sulphur hexafluoride (SonoVue) echo contrast agent. J. Cardiovasc. Med. Hagerstown Md. 2009, 10, 75–77. [Google Scholar] [CrossRef] [PubMed]
- Ionescu, A. Bubble trouble: Anaphylactic shock, threatened myocardial infarction, and transient renal failure after intravenous echo contrast for left ventricular cavity opacification preceding dobutamine stress echo. Eur. J. Echocardiogr. 2009, 10, 707–710. [Google Scholar] [CrossRef] [PubMed]
- Levano, J.A.; Jimenez, M.A.; Laiseca, A.; Vives, R. Anaphylactic shock due to SonoVue. Ann. Allergy Asthma Immunol. 2012, 108, 208–209. [Google Scholar] [CrossRef] [PubMed]
- Solivetti, F.M.; Elia, F.; Musicco, F.; Bonagura, A.C.; Di Leo, N.; Iera, J.; Drudi, F. Anaphylactic shock induced by sulphur hexafluoride in an individual with no history of heart disease: Case report and literature review. Ultraschall Med. 2012, 33, 597–598. [Google Scholar] [CrossRef] [PubMed]
- Calvo, D.; de la Hera, J.M.; Lee, D.H. Contraste ecocardiográfico y seguridad clínica [Contrast echocardiography and clinical safety]. Rev. Esp. Cardiol. 2006, 59, 399–400. (In Spanish) [Google Scholar] [CrossRef] [PubMed]
- Steinhauer, R.; Miyashita, S.; Chweich, H.; Ortoleva, J.; Downey, B.C. A rare case of echo enhancing agent anaphylaxis complicated by acute coronary syndrome. Echocardiography 2023, 40, 743–746. [Google Scholar] [CrossRef] [PubMed]
- Mikhail, E.S.; Ghaly, J.B.; Malik, B.; Ghatol, A.G. Anaphylaxis to Lumason Contrast Agent in Echocardiography after Immune Sensitization: A Case Report and Literature Review. J. Community Hosp. Intern. Med. Perspect. 2023, 13, 74–78. [Google Scholar] [CrossRef] [PubMed]
- Olson, M.C.; Atwell, T.D.; Knudsen, J.M. Anaphylactic reaction to an ultrasound contrast agent (Lumason) in a patient with systemic mastocytosis. J. Clin. Ultrasound. 2018, 46, 533–535. [Google Scholar] [CrossRef] [PubMed]
- Mansour, A.; Shinn, A.; Bataineh, M.A.; Aggarwal, K.B. Rare anaphylactic reaction to an echocardiography contrast agent. J. Am. Coll. Cardiol. 2022, 79, 3116. [Google Scholar] [CrossRef]
- Kerber, A.; Li, J.T.C. Anaphylaxis to ultrasound-enhancing agent with transient elevation in serum tryptase. Ann. Allergy Asthma Immunol. 2022, 129, 121. [Google Scholar] [CrossRef] [PubMed]
- Muraro, A.; Worm, M.; Alviani, C.; Cardona, V.; DunnGalvin, A.; Garvey, L.H.; Riggioni, C.; de Silva, D.; Angier, E.; Arasi, S.; et al. EAACI guideline:Anaphylaxis (2021 update). Allergy 2022, 77, 357–377. [Google Scholar] [CrossRef] [PubMed]
- Shang, Y.; Xie, X.; Luo, Y.; Nie, F.; Luo, Y.; Jing, X.; Liao, J.; Zheng, R.; Wu, R.; Luo, X.; et al. Safety findings after intravenous administration of sulfur hexafluoride microbubbles to 463,434 examinations at 24 centers. Eur. Radiol. 2023, 33, 988–995. [Google Scholar] [CrossRef] [PubMed]
- Simons, F.E.; Ardusso, L.R.; Bilò, M.B.; Cardona, V.; Ebisawa, M.; El-Gamal, Y.M.; Lieberman, P.; Lockey, R.F.; Muraro, A.; Roberts, G.; et al. International consensus on (ICON) anaphylaxis. World Allergy Organ J. 2014, 7, 9. [Google Scholar] [PubMed]
- Valent, P.; Akin, C.; Arock, M.; Brockow, K.; Butterfield, J.H.; Carter, M.C.; Castells, M.; Escribano, L.; Hartmann, K.; Lieberman, P.; et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: A consensus proposal. Int. Arch. Allergy Immunol. 2012, 157, 215–225. [Google Scholar] [CrossRef] [PubMed]
Authors | Allergologic History | Known Diseases | Purpose | Type of Reaction | Therapy | Allergic Evaluation |
---|---|---|---|---|---|---|
Coudray et al. (2017) [7] | No | Hypertension | Control six months after endovascular abdominal aortic aneurysm repair (EVAR) | Anaphylaxis | Epinephrine + steroids + antihistamines + volume resuscitation + oxygen | Skin prick test for SonoVue and PEG were negative, serum histamine 88.9 nmol/L and acute serum tryptase 147 mcg/L |
Geleijnse et al. (2009) [8] | Not reported | Hypertension, recent carotid stenting | Dobutamine stress echocardiography for risk stratification before aortic abdominal surgery. | Hypotension + skin erythema | Steroids + antihistamines + volume resuscitation | No |
Geleijnse et al. (2009) [8] | Not reported | Pompe disease | To investigate cardiac function | Tinnitus, dizziness, hypotension, bradycardia | Steroids + antihistamines + volume resuscitation | No |
Geleijnse et al. (2009) [8] | Not reported | Familial nonischemic dilated cardiomyopathy | To exclude non-compaction cardiomyopathy | Nausea, skin erythema, bradycardia and shock | Steroids + antihistamines + resuscitation procedure (cardiac massage and manual ventilation); after 10 h from discharge, the patient experienced pain in multiple joints lasting for 2 days | Type III allergic reaction without identification of a specific allergen |
Ionescu (2009) [9] | No | Type-II diabetes, three-vessel coronary artery disease (angioplasty 6 weeks earlier) | Before elective dobutamine stress echo | Paresthesias, dizziness, bradycardia, hypotension, erythematous skin rash, tonic-clonic fit (after hypotension therapy), myocardial ischaemia | Atropine + steroids + antihistamines + midazolam + phenylephrine | No |
Levano et al. (2012) [10] | No | Liver cirrhosis of unknown cause (Child–Pugh score B) and portal hypertension, esophageal varices | To evaluate a focal liver lesion | Anaphylaxis | Mechanical ventilation + fluids + steroids + antihistamines + norepinephrine | Skin prick and intradermal tests with SonoVue were negative, basal serum tryptase 3.74 mcg/L |
Solivetti et al. (2012) [11] | No | Melanoma (surgically removed) | To evaluate a non-painful lesion in the periscapular region (suspected in-transit metastatic melanoma lesion) | Itching, heat sensation, edema of the face, respiratory difficulty, edema of the glottis, urticaria, cardiocirculatory collapse | Oxygen + fluids + steroids + antihistamines | No |
Calvo et al. (2006) [12] | No | Acute anterior myocardial infarction and single vessel coronary disease | Elective dobutamine stress echo. | Sweating, bradycardia, hypotension and cardio-respiratory arrest | Cardiopulmonary resuscitation | No |
Steinhauer et al. (2023) [13] | No | STEMI | To evaluate for left ventricular thrombus in the setting of apical akinesis | Dyspnea, loss of pulse, diffuse erythematous rash | Cardiopulmonary resuscitation, 2 mg IV epinephrine, 200 mg IV hydrocortisone, 50 mg IV diphenhydramine | Acute serum tryptase 23.9 mcg/L |
Mikhail et al. (2023) [14] | No | Hypertension, atrial fibrillation, pericardial effusion, obstructive sleep apnea, diabetes mellitus type 2, asthma | To evaluate stroke | Shortness of breath, diaphoresis, cyanosis, hypoxia, tachycardia | Solumedrol, Albuterol, Diphenhydramine, and oxygen | No |
Olson et al. (2018) [15] | No | Myelodysplastic syndrome, systemic mastocytosis | Ultrasound-guided biopsy of hepatic mass | Apnea and pulseless electrical activity | Epinephrine and cardiopulmonary resuscitation | Acute serum tryptase 72.4 mcg/L (serum basal tryptase was 41.5 mcg/L), leukotriene E4 6750 pg/mg Cr and N-methylhistamine 3897 mcg/g Cr |
Mansour et al. (2022) [16] | No | Heart failure with preserved ejection fraction (HFpEF) | Echocardiogram to evaluate worsening dyspnea | Severe anaphylactic shock | Intravenous antihistamines, methylpredniso- lone and epinephrine | Not reported |
Kerber et al. (2022) [17] | No | Not reported | Echo stress test | Nausea, vomiting, diarrhea, hypotension and hypoxia | Epinephrine, dexamethasone, benadryl, oxygen | Transient elevation in serum tryptase |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Longhino, D.; Buonomo, A.; Zocco, M.A.; Ainora, M.E.; Esposto, G.; Mignini, I.; Cerrito, L.; Ponziani, F.R.; Gasbarrini, A.; Nucera, E.; et al. Anaphylaxis after SonoVue: A Case Report and a Literature Review. J. Clin. Med. 2024, 13, 5018. https://doi.org/10.3390/jcm13175018
Longhino D, Buonomo A, Zocco MA, Ainora ME, Esposto G, Mignini I, Cerrito L, Ponziani FR, Gasbarrini A, Nucera E, et al. Anaphylaxis after SonoVue: A Case Report and a Literature Review. Journal of Clinical Medicine. 2024; 13(17):5018. https://doi.org/10.3390/jcm13175018
Chicago/Turabian StyleLonghino, David, Alessandro Buonomo, Maria Assunta Zocco, Maria Elena Ainora, Giorgio Esposto, Irene Mignini, Lucia Cerrito, Francesca Romana Ponziani, Antonio Gasbarrini, Eleonora Nucera, and et al. 2024. "Anaphylaxis after SonoVue: A Case Report and a Literature Review" Journal of Clinical Medicine 13, no. 17: 5018. https://doi.org/10.3390/jcm13175018